Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats-Reference-Cited by-同舟云学术

Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer's-like pathology and symptoms through multiple targeting actions in aged T2D rats

Published:2023-04 Issue: Volume:117 Page:109927
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Gomaa Adel A.,Farghaly Hanan S.M.,Ahmed Asmaa M.,Hemida Fahmy K.

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference79 articles.

1. WHO, 2021, World Health Organization, Dementia (2021) https://www .who.int/news-room/fact-sheets/detail/dementia.

2. Statistics D, 2021, Alzheimer’s Disease International, dementia-statistic (2021), https://www.alzint.org/about/dementia-facts-figures/ dementia-statistic.

3. Aducanumab for Alzheimer’s disease: A regulatory perspective;Nisticò;Pharmacol. Res.,2021

4. Failure to demonstrate efficacy of aducanumab: An analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019;Knopman;Alzheimers Dement.,2021

5. Effect of reductions in amyloid levels on cognitive change in randomized trials: Instrumental variable meta-analysis;Ackley;BMJ,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective Effects of Phlorizin on Hyperlipidemia-induced Myocardial Injury: Involvement of Suppression in Pyroptosis via Regulating HK1/NLRP3/Caspase-1 Signaling Pathway;Applied Biochemistry and Biotechnology;2024-09-03

2. PHOSPHODIESTERASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE;INDIAN DRUGS;2024-07-28

3. Identification of vilazodone as a novel plasminogen activator inhibitor to overcome Alzheimer's disease through virtual screening, molecular dynamics simulation, and biological evaluation;Archiv der Pharmazie;2024-05-30

4. Natural and Synthetic Phosphodiesterase Inhibitors in 2023: an Update on the Impact on Neurological and Psychiatric Conditions;Mini-Reviews in Medicinal Chemistry;2023-10-04

5. Adipocyte-Derived Small Extracellular Vesicles from Patients with Alzheimer Disease Carry miRNAs Predicted to Target the CREB Signaling Pathway in Neurons;International Journal of Molecular Sciences;2023-09-13